2-(4-(5-(2-(3,5-dimethylphenoxy)pyrimidin-4-yl)-4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)piperidin-1-yl)ethan-1-amine

ID: ALA5288200

Chembl Id: CHEMBL5288200

Max Phase: Preclinical

Molecular Formula: C29H31F3N6O

Molecular Weight: 536.60

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C)cc(Oc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)ncn3C3CCN(CCN)CC3)n2)c1

Standard InChI:  InChI=1S/C29H31F3N6O/c1-19-15-20(2)17-24(16-19)39-28-34-11-7-25(36-28)27-26(21-3-5-22(6-4-21)29(30,31)32)35-18-38(27)23-8-12-37(13-9-23)14-10-33/h3-7,11,15-18,23H,8-10,12-14,33H2,1-2H3

Standard InChI Key:  MBTPASBIFTUPRT-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5288200

    ---

Associated Targets(Human)

BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 536.60Molecular Weight (Monoisotopic): 536.2511AlogP: 6.03#Rotatable Bonds: 7
Polar Surface Area: 82.09Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.47CX LogP: 5.45CX LogD: 3.35
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.31Np Likeness Score: -1.11

References

1. Fu Y, Zhang Y, Sun H..  (2021)  Progress in the development of domain selective inhibitors of the bromo and extra terminal domain family (BET) proteins.,  226  [PMID:34547507] [10.1016/j.ejmech.2021.113853]

Source